MBNL2 and breast carcinoma: Finally, we obtained 9 MBNL2-targeting miRNAs that were upregulated in breast cancer, including miR-182, miR-429, miR-97, miR-33a, miR-183, miR-200c, miR-493, miR-200b and miR-32 (Figure 4B).